Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

SELL
$304.11 - $351.99 $15,205 - $17,599
-50 Reduced 1.68%
2,927 $1.01 Million
Q4 2023

Feb 12, 2024

BUY
$269.37 - $365.04 $2,693 - $3,650
10 Added 0.34%
2,977 $961,000
Q3 2023

Nov 13, 2023

SELL
$350.25 - $422.63 $76,004 - $91,710
-217 Reduced 6.82%
2,967 $1.06 Million
Q2 2023

Aug 09, 2023

SELL
$359.49 - $486.4 $34,511 - $46,694
-96 Reduced 2.93%
3,184 $1.21 Million
Q1 2023

May 08, 2023

BUY
$418.69 - $503.0 $441,717 - $530,665
1,055 Added 47.42%
3,280 $1.57 Million
Q4 2022

Feb 14, 2023

BUY
$351.71 - $456.01 $8,089 - $10,488
23 Added 1.04%
2,225 $935,000
Q3 2022

Nov 07, 2022

BUY
$412.59 - $563.26 $16,503 - $22,530
40 Added 1.85%
2,202 $918,000
Q2 2022

Aug 10, 2022

SELL
$463.67 - $597.16 $49,149 - $63,298
-106 Reduced 4.67%
2,162 $1.07 Million
Q1 2022

May 12, 2022

SELL
$524.57 - $735.42 $362,477 - $508,175
-691 Reduced 23.35%
2,268 $1.28 Million
Q4 2021

Feb 11, 2022

SELL
$708.84 - $794.68 $77,263 - $86,620
-109 Reduced 3.55%
2,959 $2.24 Million
Q3 2021

Nov 10, 2021

SELL
$657.71 - $825.77 $263,084 - $330,308
-400 Reduced 11.53%
3,068 $2.29 Million
Q2 2021

Aug 11, 2021

SELL
$576.64 - $649.04 $104,371 - $117,476
-181 Reduced 4.96%
3,468 $2.23 Million
Q1 2021

May 14, 2021

BUY
$547.01 - $662.35 $284,445 - $344,422
520 Added 16.62%
3,649 $2.12 Million
Q4 2020

Feb 12, 2021

SELL
$510.68 - $643.45 $327,856 - $413,094
-642 Reduced 17.02%
3,129 $1.82 Million
Q3 2020

Nov 12, 2020

SELL
$454.43 - $535.6 $702,094 - $827,502
-1,545 Reduced 29.06%
3,771 $1.94 Million
Q2 2020

Aug 12, 2020

SELL
$334.87 - $493.06 $1.21 Million - $1.78 Million
-3,611 Reduced 40.45%
5,316 $2.3 Million
Q1 2020

May 11, 2020

BUY
$320.01 - $409.07 $88,642 - $113,312
277 Added 3.2%
8,927 $3.13 Million
Q4 2019

Feb 07, 2020

SELL
$319.73 - $374.2 $139,082 - $162,777
-435 Reduced 4.79%
8,650 $3.2 Million
Q3 2019

Nov 04, 2019

SELL
$304.55 - $345.24 $621,586 - $704,634
-2,041 Reduced 18.34%
9,085 $3.02 Million
Q2 2019

Aug 05, 2019

SELL
$286.93 - $312.59 $804,551 - $876,502
-2,804 Reduced 20.13%
11,126 $3.48 Million
Q1 2019

May 01, 2019

SELL
$224.3 - $317.41 $55,402 - $78,400
-247 Reduced 1.74%
13,930 $4.26 Million
Q4 2018

Feb 11, 2019

BUY
$220.1 - $309.0 $1.57 Million - $2.2 Million
7,132 Added 101.23%
14,177 $3.29 Million
Q3 2018

Nov 08, 2018

SELL
$289.28 - $326.15 $1.14 Million - $1.29 Million
-3,942 Reduced 35.88%
7,045 $2.21 Million
Q2 2018

Aug 07, 2018

SELL
$244.1 - $303.88 $4.37 Million - $5.44 Million
-17,913 Reduced 61.98%
10,987 $3.17 Million
Q1 2018

May 09, 2018

SELL
$233.97 - $274.11 $2.86 Million - $3.35 Million
-12,210 Reduced 29.7%
28,900 $7.23 Million
Q4 2017

Feb 09, 2018

BUY
$216.94 - $271.3 $454,706 - $568,644
2,096 Added 5.37%
41,110 $9.86 Million
Q3 2017

Nov 09, 2017

BUY
$212.27 - $242.28 $8.28 Million - $9.45 Million
39,014
39,014 $8.69 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.1B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Eagle Asset Management Inc Portfolio

Follow Eagle Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Asset Management Inc with notifications on news.